Mozambique vs Sierra Leone: Access to anti-retroviral drugs, male
Mozambique
82.0%
in 2024
Sierra Leone
82.0%
in 2024
Mozambique rank
42nd
Sierra Leone rank
42nd
Access to anti-retroviral drugs, male over time
- Mozambique
- Sierra Leone
How they compare
Mozambique currently reports 82.0% against 82.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Sierra Leone ahead.
Mozambique ranks 42nd and Sierra Leone ranks 42nd of 141 countries.
Mozambique has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5% | 1.5% | 2.0% | Mozambique |
| 2010s | 30.7% | 16.7% | 14.0% | Mozambique |
| 2020s | 68.6% | 56.8% | 11.8% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Mozambique or Sierra Leone?
- Mozambique, at 82.0% against 82.0% in Sierra Leone as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Mozambique and Sierra Leone?
- 0.0%, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Sierra Leone?
- 25 years are reported by both, from 2000 to 2024.
- How do Mozambique and Sierra Leone rank globally for access to anti-retroviral drugs, male?
- Mozambique ranks 42nd and Sierra Leone ranks 42nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.